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Abstract 
Background: Precursor B-cell acute lymphoblastic leukemia accounts for 2% of all 
lymphoid neoplasms in the United States and occurs most frequently in childhood, but 
can also occur in adults with a median age of 39 years. It is more commonly seen in males 
and in Caucasians.  
Case Report: We present a case of a 51-year-old Caucasian female with the development 
of precursor B-cell acute lymphoblastic leukemia after suffering acute hepatitis A 
4 weeks prior to her diagnosis. She presented with malaise for a month without 
spontaneous bruising/bleeding, infections, or B-symptoms, such as fevers, night sweats, 
or unintentional weight loss.  
Conclusion: Nonspecific viral transformation of bone marrow has been discussed in the 
literature, but we specifically describe hepatitis A-induced adult-onset precursor B-cell 
acute lymphoblastic leukemia, which is the first reported case in the literature. 
 
Introduction 
Classically, precursor acute lymphoblastic leukemia (ALL) is most commonly a 
childhood disease that is extremely responsive to chemotherapy (88%) and has an 
excellent prognosis in most cases. ALL has known associations with radiation exposure, 
benzene, hair dyes, and Down syndrome. In addition to these risk factors, adult-onset or 
atypical ALL may also be a complication of previous chemotherapy regimens. Unlike its 
childhood counterpart, adult-onset ALL has an unfavorable response to chemotherapy 
(20–40%) and has a poor prognosis. In the literature, there have been numerous  










references to a viral etiology involved in the pathophysiology and transformation of the 
bone marrow in children predisposing them to the development of ALL. However, there 
have not been any cases reported in the literature that were able to establish a causal 
relationship between ALL and a viral infection in a temporal manner. 
We report a case of acute hepatitis A-induced adult-onset precursor B-cell ALL, which 
is, to our knowledge, the first reported case in the literature. This paper reports a case 
where acute viral transformation of the bone marrow took place in a rather short time 
period. 
Case Presentation 
A 51-year-old Caucasian female with a history of migraine headaches managed with Topamax for 
the last year presented with increased malaise and fatigue when walking up a flight of stairs. These 
symptoms had been occurring for the previous month. Several months prior, she had had normal 
laboratory studies and had been in great health. A day prior to her admission, she had been found to 
have severe anemia by her outpatient physician and was hospitalized for further evaluation. Her 
physical assessment showed pallor and splenomegaly without any lymphadenopathy or bruises. 
Computed tomography of the head, thorax, abdomen, and pelvis, checking for malignancy, was 
unremarkable except for splenomegaly. Complete blood count at the time of admission showed 
pancytopenia with a hematocrit (Hct) of 15%, a platelet count of 17,000, a white blood cell count of 1.58 
K/mm
3, with no indication of hemolysis or reticulocytosis. She was transfused with 5 units of blood 
during her hospital course, which increased her Hct up to 24.7%, but was not an appropriate response. 
The patient also had an alanine transaminase level of 2,840 IU/l and an aspartate transferase level of 
1,600 IU/l in the absence of hypotension, which warranted acute hepatitis serologies. Hepatitis 
serologies were negative for hepatitis B and C antibody, but positive for hepatitis A IgM antibody. 
Further questioning after the identification of the positive hepatitis IgM antibody revealed that the 
patient had experienced a bout of extreme diarrhea, nausea, vomiting, extreme malaise, and yellow-
colored skin approximately a month prior to her admission. According to the laboratory findings and 
history, the patient had suffered acute hepatitis A approximately 1 month prior to her admission, from 
which she had recovered spontaneously without medical treatment. Evaluation of her pancytopenia 
revealed a negative Monospot test, but she was found to have high titers of Epstein-Barr virus (EBV), 
antibody IgG and EBV nuclear antigen antibody IgG, which was consistent with an old or a 
convalescent phase of EBV infection and ruled out EBV as a cause of her pancytopenia. 
Hepatitis A-induced aplastic anemia along with the ingestion of Topamax were considered as 
possible causes of the bone marrow depression, although Topamax is not classically associated with 
blood dyscrasias. A peripheral blood smear revealed 54% immature cells, true thrombocytopenia and 
the absence of hemolysis. Because her pancytopenia did not resolve, a bone marrow biopsy was 
warranted, which revealed a B-cell lymphoproliferative disorder (fig. 1, fig. 2). Immunostain markers 
for CD3 and CD5 were negative. However, markers were diffusely positive for CD10 and CD20 and a 
subsequent flow cytometry confirmed precursor B-cell ALL. Molecular genetic analysis was positive for 
the Philadelphia chromosome, which occurs in 25% of the adult ALL cases. The incidence increases 
with age, approaching 50% in patients older than 50 years of age. ALL cases with a positive Philadelphia 
chromosome have a worse prognosis and therefore our patient immediately received induction 
chemotherapy. 
Discussion 
ALL typically affects patients between 2 and 5 years of age with symptoms of fever, 
bleeding, bone pain and lymphadenopathy. Our patient was diagnosed with precursor B-
cell ALL at the age of 51 with no risk factors (including family history) in the setting of 
recent Topamax use, acute hepatitis A, and high Epstein-Barr viral titers. Unlike other 
anti-epileptic drugs, there are no reports of Topamax causing bone marrow dysplasia at  










either therapeutic dosages for seizures or migraine headaches. On the other hand, EBV-
associated hepatitis could occur with aplastic anemia [1]. EBV-induced aplastic anemia 
presents in the setting of Burkitt’s lymphoma, acute infection or reactivation in the 
immunodeficient. However, our patient’s laboratory evaluation revealed an EBV IgG 
antibody and EBNA IgG antibody consistent with an old or convalescent EBV infection. 
Thus, the possibility of an acute EBV hepatitis or Topamax-induced bone marrow 
suppression in the aforementioned setting would be nullified even in the absence of the 
peripheral smear or bone marrow results. 
Acute hepatitis A manifests as fever, nausea, vomiting, abdominal pain, and jaundice. 
Fecal-oral transmission is predominant, which explains the increased prevalence of acute 
hepatitis A in developing countries. Although major hematologic manifestations of acute 
hepatitis A are rare, transient granulocytopenia and thrombocytopenia are often seen 
with extremes of aplastic anemia [2–4]. The hematological mechanisms of hepatitis A are 
variable. Hepatitis A virus can induce an autoimmune reaction [5] and chromosomal 
damage in the hematopoietic system with subsequent stem-cell failure [6]. In some cases, 
liver cell damage impairs the detoxifying metabolism of drugs with subsequent bone 
marrow toxicity [7, 8]. Viral hepatitis A has numerous mechanisms of action, which 
allows it to impact the bone marrow in a complex way [5, 6]. The major differential in our 
case was related to hepatitis A-induced aplastic anemia, which was ruled out with the 
peripheral smear as well as the bone marrow biopsy. 
There are several models reviewed by the National Institute of Health that support an 
infectious etiology to ALL induction [9]. One of the models specifically views ALL as a 
rare response to a childhood infection and assumes that the leukemia-inducing effect is 
related to the timing of the infection, with a greater leukemic effect with later infections as 
opposed to those which occurred in infancy [9]. In fact, this suspicion was so strong that 
various viruses from the Polyomaviridae family, such as JC virus and BK virus, have been 
sequenced and compared to childhood ALL sequences; however, there was no causal 
relationship with these viruses [10]. In a review regarding the etiology of acute childhood 
leukemias, it was concluded that delayed dysregulated responses to common infectious 
agents played a major part in the conversion of preleukemic clones that were present 
genetically into overt precursor B-cell ALL [11]. If common infectious agents can induce 
such a transformation, one can only speculate the impact of a severe viral infection, such 
as acute hepatitis A. This concept supports the classic ‘two-hit hypothesis’ in many 
‘nature combined with nurture’ models of disease, which describe a genetically 
predisposed individual (nature), who is environmentally exposed to a severe insult 
(nurture). Similar models have been referenced in the pathogenesis of inflammatory 
bowel disease in relation to gut microbial flora. Additionally, in the pediatric population, 
it is difficult to assess the degree of delay and transformation into overt ALL as there are 
numerous variables which influence the outcome in patients at risk [12]. However, this 
issue is not significant in our patient due to the timing and course of her acute hepatitis A 
infection. Lastly, there is the rare possibility that precursor B-cell ALL developed 
independently of her acute hepatitis A, but there are no reported cases in the literature 
where acute hepatitis A independently occurred in a chronological fashion with precursor 
B-cell ALL. 
Our patient had been serially followed by her primary care physician throughout her 
life and had never had any evidence of blood dyscrasias. Immediately prior to her 
hepatitis A infection, she had been in good health and had a normal laboratory  










evaluation. Approximately 2 weeks after her acute hepatitis infection, she had a low Hct at 
another hospital; then she developed pancytopenia 2 weeks later, at the time she was 
admitted to our facility. In a thorough review of the literature, no reported cases with this 
type of temporal and causal relationship of a proven viral infection subsequently inducing 
acute lymphoblastic transformation were found. We propose that this viral 
transformation was induced through one of the previously mentioned mechanisms, such 
as chromosomal damage to the hematopoietic system. 
In conclusion, this case illustrates a temporal, chronological, and causal relationship in 
which bone marrow transformation was induced by an acute hepatitis A infection leading 
to precursor B-cell ALL in the absence of any other known risk factors. To our 
knowledge, this is the first such case reported in the literature. 
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Fig. 1. Photomicrograph of bone marrow biopsy showing 100% cellularity. 
 
  











Fig. 2. Complete replacement of bone marrow by neoplastic lymphoid cells. 
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